112 related articles for article (PubMed ID: 9566055)
1. Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.
Pałucha A; Brański P; Tokarski K; Bijak M; Pilc A
Pol J Pharmacol; 1997; 49(6):495-7. PubMed ID: 9566055
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.
Pilc A; Brański P; Pałucha A; Tokarski K; Bijak M
Eur J Pharmacol; 1998 May; 349(1):83-7. PubMed ID: 9669500
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of mGluR5 by antisense deoxynucleotides alters pharmacological responses to applications of ACPD in the rat hippocampus.
Dorri F; Hampson DR; Baskys A; Wojtowicz JM
Exp Neurol; 1997 Sep; 147(1):48-54. PubMed ID: 9294402
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes.
Ye ZC; Sontheimer H
Glia; 1999 Feb; 25(3):270-81. PubMed ID: 9932873
[TBL] [Abstract][Full Text] [Related]
5. Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical studies.
Smiałowska M; Bajkowska M
Pol J Pharmacol; 1997; 49(5):357-62. PubMed ID: 9566036
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of low and high concentrations of group I metabotropic receptor agonists on field potentials in the hippocampal CA1 region in vitro.
Zahorodna A; Pałucha A; Bijak M
Pol J Pharmacol; 1998; 50(4-5):291-8. PubMed ID: 10091713
[TBL] [Abstract][Full Text] [Related]
7. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
Cahusac PM; Wan H
Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
[TBL] [Abstract][Full Text] [Related]
8. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.
Schoepp DD; Salhoff CR; Wright RA; Johnson BG; Burnett JP; Mayne NG; Belagaje R; Wu S; Monn JA
Neuropharmacology; 1996; 35(12):1661-72. PubMed ID: 9076745
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus.
Bajkowska M; Brański P; Smiałowska M; Pilc A
Pol J Pharmacol; 1999; 51(6):539-41. PubMed ID: 10817534
[TBL] [Abstract][Full Text] [Related]
10. Involvement of hippocampal metabotropic glutamate receptors in radial maze performance.
Hayashi K; Yoshihara T; Ichitani Y
Neuroreport; 2007 May; 18(7):719-23. PubMed ID: 17426606
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of learning and recall of a spatial task on phosphoinositide hydrolysis induced by the metabotropic glutamate receptor agonist 1S,3R-ACPD (1S,3R-1-amino-cyclopentane-1,3-discarboxylic acid) in the hippocampus and the prefrontal cortex of rats.
de Bruin JP; Facchinetti F; Toth E; Balazs R; Joosten RN
Neurosci Lett; 1996 Feb; 204(1-2):57-60. PubMed ID: 8929977
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid-, except 1S,3R-ACPD, induced transient high stimulation of phosphoinositide metabolism during hippocampal neuron development.
Blanc EM; Vignes MH; Récasens M
Int J Dev Neurosci; 1995 Nov; 13(7):723-37. PubMed ID: 8787863
[TBL] [Abstract][Full Text] [Related]
13. Imipramine-induced increase in the inhibitory effect of adenosine receptor activation in the hippocampus.
Zahorodna A; Bijak M
Pol J Pharmacol; 1999; 51(5):423-8. PubMed ID: 10817543
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic depression of inhibitory postsynaptic potentials by metabotropic glutamate receptors in rat hippocampal CA1 pyramidal cells.
Jouvenceau A; Dutar P; Billard JM
Eur J Pharmacol; 1995 Aug; 281(2):131-9. PubMed ID: 7589200
[TBL] [Abstract][Full Text] [Related]
15. Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors.
Zalewska A; Wiśniewski K
Pol J Pharmacol; 1997 Aug; 49(4):239-48. PubMed ID: 9437767
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical and pharmacological characterization of metabotropic glutamate receptors of the vestibular end organs in the frog.
Andrianov GN; Puyal J; Raymond J; Ventéo S; Demêmes D; Ryzhova IV
Hear Res; 2005 Jun; 204(1-2):200-9. PubMed ID: 15925205
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of 1S,3R-ACPD-induced neuroprotection in rat hippocampal slices subjected to oxygen and glucose deprivation.
Small DL; Monette R; Chakravarthy B; Durkin J; Barbe G; Mealing G; Morley P; Buchan AM
Neuropharmacology; 1996; 35(8):1037-48. PubMed ID: 9121606
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor subtypes differentially influence neuronal recovery from in vitro hypoxia/hypoglycemia in rat hippocampal slices.
Opitz T; Richter P; Carter AJ; Kozikowski AP; Shinozaki H; Reymann KG
Neuroscience; 1995 Oct; 68(4):989-1001. PubMed ID: 8545005
[TBL] [Abstract][Full Text] [Related]
19. [Effect of trans-ACPD, a specific agonist of glutamate interacting with metabotropic receptors, on synaptic transmission in the rat hippocampus].
Garashchuk OV; Koval'chuk IuN; Kryshtal' OA
Neirofiziologiia; 1992; 24(2):211-4. PubMed ID: 1350854
[TBL] [Abstract][Full Text] [Related]
20. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]